[1]李玉泉.心肌酶谱水平检测诊断心力衰竭的意义[J].医学信息,2020,33(06):172-173.[doi:10.3969/j.issn.1006-1959.2020.06.059]
　LI Yu-quan.Significance of Myocardial Enzyme Level Detection in Diagnosis of Heart Failure[J].Medical Information,2020,33(06):172-173.[doi:10.3969/j.issn.1006-1959.2020.06.059]
点击复制

心肌酶谱水平检测诊断心力衰竭的意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年06期
页码:
172-173
栏目:
诊疗技术
出版日期:
2020-03-15

文章信息/Info

Title:
Significance of Myocardial Enzyme Level Detection in Diagnosis of Heart Failure
文章编号:
1006-1959（2020）06-0172-02
作者:
李玉泉
（天津市津南医院检验科，天津 300350）
Author(s):
LI Yu-quan
(Department of Laboratory Medicine,Tianjin Jinnan Hospital,Tianjin 300350,China)
关键词:
心肌酶谱; 心力衰竭; 诊断价值
Keywords:
Myocardial enzyme spectrum; Heart failure; Diagnostic value
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2020.06.059
文献标志码:
A
摘要:
目的 研究心肌酶谱水平检测在诊断心力衰竭患者中的价值。方法 选取2018年1月~2019年1月在我院诊治的120例心力衰竭患者设为观察组，选取同期体检健康者80例设为对照组，检测心肌酶谱乳酸脱氢酶（LDH）、肌酸激酶（CK）、α羟基丁酸脱氢酶（α-HBDH）、肌酸激酶同工酶（CK-MB）水平，比较两组心肌酶谱水平、观察组不同心功能分级患者心肌酶谱水平及治疗前后心肌酶谱水平。结果 观察组治疗前LDH、CK、α-HBDH、CK-MB均高于对照组，差异有统计学意义（P＜0.05）；治疗后观察组LDH、CK、α-HBDH、CK-MB均低于治疗前，且高于对照组，差异有统计学意义（P＜0.05）；心功能Ⅱ、Ⅲ、Ⅳ级患者LDH、CK、α-HBDH、CK-MB水平均高于心功能Ⅰ级患者，差异有统计学意义（P＜0.05），心功能分级越高，患者的心肌酶谱指标水平越高。结论 心力衰竭患者心肌酶谱水平高于健康人群，且心功能越差，心肌酶谱水平越高，临床检测心肌酶谱水平可为心力衰竭患者的诊断、治疗以及心衰情况提供参考依据。
Abstract:
Objective To study the value of detection of myocardial enzymes in the diagnosis of patients with heart failure.Methods 120 patients with heart failure diagnosed and treated in our hospital from January 2018 to January 2019 were selected as the observation group, and 80 healthy patients who were checked during the same period were selected as the control group. The myocardial enzyme lactate dehydrogenase (LDH), muscle Acid kinase (CK), α-hydroxybutyric acid dehydrogenase (α-HBDH), creatine kinase isoenzyme (CK-MB) levels, compare the levels of myocardial enzymes in the two groups, and compare the myocardial enzymes in patients with different cardiac function grades levels and myocardial enzymes before and after treatment.Results The LDH, CK, α-HBDH, and CK-MB in the observation group were higher than those in the control group before treatment,the differences were statistically significant (P<0.05).After treatment, the LDH, CK, α-HBDH, and CK-MB in the observation group were lower than before treatment and higher than the control group,the difference was statistically significant (P<0.05); The levels of LDH, CK, α-HBDH, and CK-MB in patients with cardiac function Ⅱ, Ⅲ, and Ⅳ were higher than those in patients with cardiac function Ⅰ,the difference was statistically significant (P<0.05),and the higher the cardiac function classification, the higher the level of myocardial enzymes.Conclusion The level of myocardial enzymes in patients with heart failure is higher than that in healthy people, and the worse the heart function, the higher the level of myocardial enzymes. The clinical detection of myocardial enzymes can provide reference for the diagnosis, treatment and heart failure of patients with heart failure.

参考文献/References:

[1]谭苏华.血清BNP、cTnI及心肌酶谱水平检测在心力衰竭患者中的应用价值[J].检验与临床,2016,10(1):271.[2]常当宁.探讨心力衰竭患者治疗前后心肌酶、肌钙蛋白、C-反应蛋白水平的变化[J].吉林医学,2013,34(14):2677-2678.[3]胡江乔,皮林,宋丽芬,等.心力衰竭药物治疗前后患者心肌酶、cTnI、CＲP水平的变化[J].中国医药导刊,2016,18(6):614-615.[4]陈惠英,刘锦光,李惠兰.血清NT-proBNP及心肌酶谱与先天性心脏病的相关性[J].现代医院,2014,14(5):19-21.[5]李军,马科,曹秀丽,等.血清脑钠肽、心肌肌钙蛋白及心肌酶谱水平在心力衰竭患者中的检测价值[J].国际老年医学杂志,2016,37(4):159-162.

相似文献/References:

[1]郭俊林,张立.BNP对CRT后期疗效的临床评价[J].医学信息,2018,31(01):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
　GUO Jun-lin,ZHANG li.Clinical Evaluation of BNP in Treatment of Late CRT[J].Medical Information,2018,31(06):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
[2]孙朝霞,曹显刚,赵 利,等.发热伴血小板减少综合征患者D-二聚体、心肌酶谱及肝酶谱的检测[J].医学信息,2018,31(03):85.[doi:10.3969/j.issn.1006-1959.2018.03.026]
　SUN Zhao-xia,CAO Xian-gang,ZHAO li,et al.Detection of D-Dimer,Myocardial and Liver Enzymes in Patients with Fever and Thrombocytopenia Syndrome[J].Medical Information,2018,31(06):85.[doi:10.3969/j.issn.1006-1959.2018.03.026]
[3]程 林.重组人脑利钠肽用于重症急性心肌炎伴 心力衰竭患者治疗的临床研究[J].医学信息,2018,31(08):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
　CHENG Lin.Clinical Study of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Severe Acute Myocarditis and Heart Failure[J].Medical Information,2018,31(06):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
[4]胡丽君.螺内酯联合曲美他嗪治疗慢性心力衰竭的疗效分析[J].医学信息,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
　HU Li-jun.Efficacy of Spironolactone Combined with Trimetazidine in the Treatment of Chronic Heart Failure[J].Medical Information,2018,31(06):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
[5]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(06):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[6]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
　PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Medical Information,2022,35(06):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
[7]刘革铭,马洪俊,刘 毅,等.心力衰竭的机制及诊疗的研究[J].医学信息,2022,35(10):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
　LIU Ge-ming,MA Hong-jun,LIU Yi,et al.Mechanism, Diagnosis and Treatment of Heart Failure[J].Medical Information,2022,35(06):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
[8]黄光明,赵兴昌,符显昭.水中运动联合中药内治对糖尿病大鼠心肌细胞凋亡和心功能的影响[J].医学信息,2022,35(11):72.[doi:10.3969/j.issn.1006-1959.2022.11.020]
　HUANG Guang-ming,ZHAO Xing-chang,FU Xian-zhao.Effects of Aquatic Therapeutic Exercise Combined with Traditional Chinese Medicine Internal Treatment on Cardiomyocyte Apoptosis and Cardiac Function in Diabetic Rats[J].Medical Information,2022,35(06):72.[doi:10.3969/j.issn.1006-1959.2022.11.020]
[9]何玲玲,程淑芬.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭疗效观察[J].医学信息,2018,31(13):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
　HE Ling-ling,CHENG Shu-fen.Therapeutic Effect of Trimetazidine Combined with Metoprolol Succinate in the Treatment of Coronary Heart Disease with Heart Failure[J].Medical Information,2018,31(06):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
[10]赵 维,廖荣宏,王爱华.糖皮质激素治疗心力衰竭疗效与安全性的Meta分析[J].医学信息,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
　ZHAO Wei,LIAO Rong-hong,WANG Ai-hua.Meta-analysis of the Efficacy and Safety of Glucocorticoids in the Treatment of Heart Failure[J].Medical Information,2018,31(06):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]

更新日期/Last Update: 2020-03-15